HbA1c Testing devices – Brief Summary & Analysis
HbA1c is a modified form of hemoglobin and hemoglobin is the molecule present in red blood cells of humans that carry oxygen around the body. The majority of hemoglobin is a type called HbA with a small fraction of HbA becomes modified during its lifetime into HbA1. During the late 1950s, scientists found that HbA1 could be separated further into HbA1a, HbA1b, and HbA1c out of which HbA1c is found in uncharacteristically high levels in diabetic patients.
The HbA1c formation occurs due to the attachment of more glucose molecules in a process called glycosylation The longer the blood glucose levels are high, the more glcosylation will occur and therefore the HbA1c test is currently the best way to check if diabetes is under control or not. There are various types of HbA1c testing devices available in the HbA1c testing devices market that helps in monitoring the blood glucose levels as well as in diabetic management for those suffering from diabetic Mellitus and other chronic diseases.
Global HbA1c testing device market -An HbA1c Testing devices Market outlook
According to the global HbA1c Testing devices Market Research Reports – Hemoglobin A1c (HbA1c) or glycated hemoglobin testing is one of the rapidly growing markets in the diagnostic industry essentially in the field of point of care diagnostics (POC) this market is gaining momentum over the last decade. With the diabetes mellitus, reaching epidemic levels there are strong growth opportunities for diabetes diagnostic and monitoring devices or tools that include HbA1c Testing devices. The Global HbA1c Testing Device Market worth is around the US $1.20 billion in 2015 and is expected to reach approximately the US $2.20 billion by the end of 2021 growing at a CAGR of 11% between 2016 and 2021.
The adoption of HbA1c tests is gradually rising in recent years with laboratory analyzers strengthening their existing position with a significant growth being driven by Point of Care (POC) devices. POC devices are bringing change in overall diabetes management and lifestyle of the individual with POC testing comparatively cheaper than laboratory testing. The HbA1c testing devices market is flooded by a large number of devices with new devices in the pipeline coming up every other day. In addition, physicians are increasingly prescribing the HbA1c test to their patients that are leading to an increase in the test volume. It is estimated that globally around $ 673 billion healthcare expenditure is spent on diabetic management, which is 12% of the total healthcare expenditure.
With the emerging technologies for diabetic management and increasing awareness of diabetic preventive care is fueling the growth of global HbA1c testing device market. The HbA1c Testing devices Market price is available across the open market starting at or below $100 to $3000 and above in case sophisticated devices. With an increasing home care service and demand for home care HbA1c testing devices, the overall HbA1c testing devices market outlook will stay positive in the medium to long term.
Global HbA1c Testing Devices Market – Graphical Representation
The expansion of HbA1c Testing devices Market size largely depends upon the untapped market and an increasing demand for medical tourism in developing nations would open new opportunities for this market. The global HbA1c testing devices market size and growth terms of revenue from the period 2015 to 2021 (estimated) in US dollars is shown in graphical representation as herein below
Classification of HbA1c Devices Market – A segmented view
As per the HbA1c Testing devices Market Analysis Report, the global HbA1c testing devices market is segmented into Type, Technology End User, and Geography as shown in tabulated format for the readers as shown herein under-
|Hand Held Devices||Ion-exchange HPCL||Hospital||North America|
|Bench Top Devices||Enzymatic assay||Home Care||Europe|
|Affinity binding chromatography||Diagnostic laboratory||Asia-Pacific|
|Turbidimetric Inhibition immunoassay and other||Research Institution||Latin America|
Figure: 2 – Market Segmentation of HbA1c Devices Market
Bench-top HbA1c testing service holds the largest share of more than 65% in 2015. Geographically, North America is the leading market for diabetic care device market in terms of revenue followed by Europe due to the availability of advanced technologies and infrastructure facilities. Asia-Pacific Markets holds huge potential for HbA1c devices market due to growing population and a very high incidence of diabetes and other chronic diseases among its population.